Search Tag: Abbott
Abbott Announces CE Mark For its "Alinity S" Blood and Plasma Screening System
2017 12 Jan
Abbott (NYSE: ABT) has announced its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other countries that recognize CE Mark. The new testing solution is designed to screen blood and plasma faster and more efficiently within a smaller footprint than Abbott's current systems. In a testing specialty... Read more
Establishment of Ambulatory Emergency Services at James Paget University Hospital
2016 09 Dec
INTRODUCTION A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero).1 This suggests that many emergency patients could benefit from ambulatory emergency care (AEC).1 Fundamental to AEC is the identification and management of patients with acute medical... Read more
Abbott To Take Over St Jude in $25 bln Mega-Cardio Deal
2016 28 Apr
Abbott Laboratories is taking over St. Jude Medical Inc. in a deal worth $25 bln that will create a giant in the cardio-related devices market. The two NYSE-listed companies said in a joint announcement that the combination will “create a premier medical device leader and strengthen Abbott’s long-term growth potential.” They added that the merged... Read more
Abbott to Acquire Alere,Becoming Leader in Point of Care Testing & Advancing Global Diagnostics
2016 18 Feb
ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS- Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close- Acquisition will provide access to new product applications, channels and geographies- Alere's... Read more
Rapid Pathogen Testing With PCR/ESI-MS In Practice
2015 31 Dec
Kristoffer Strålin, MD, PhD, is Associate Professor and Senior Consultant at the Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden. Karolinska Institute is a world renowned medical university, which has the mission of improving people’s health through research and education. Together with Karolinska University Hospital, it is... Read more
Innovation To ID Infection Source Without Blood Culture
2014 16 Sep
A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately $2.2 million (€1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly IlL... Read more
Abbott Tops Industry List for Economic and Social Performance
2014 15 Sep
Abbott, a global healthcare organisation, has been named the second leading company in the pharmaceutical industry by the Dow Jones Sustainability Index (DJSI) for the second consecutive year. This is one of the most prestigious global benchmarks for corporate responsibility and sustainability. Abbott is an industry group leader in healthcare equipment... Read more
Oral Nutritional Supplements in the Hospital Demonstrate Significant Health & Cost Benefits
2013 04 Sep
A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for... Read more
New Data for Abbott’s High Sensitive Troponin Test Shows It May Predict Heart Attack Risk
2013 01 Aug
Abbott announced on July 30, 2013, promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay presented at this year’s American Association for Clinical Chemistry (AACC) annual meeting in Houston, Texas. The study, conducted by researchers at Brigham and Women’s Hospital, demonstrated that Abbott’s hsTnI test (currently... Read more
Abbott Previews Next-Generation Blood Screening Prototype during ISBT Meeting in Amsterdam
2013 04 Jun
Abbott previewed a prototype for the company’s next-generation blood screening system at an event coinciding with this year’s International Society of Blood Transfusion (ISBT) Meeting in Amsterdam from June 2-5, 2013. Abbott’s new system features a user-responsive design based upon insights provided by leading blood screening experts from around the... Read more
